(RTTNews) – Quoin Pharmaceuticals, Inc. (QNRX), a clinical-stage specialty pharmaceutical company, on Wednesday, announced positive interim data from two ongoing clinical trials for topical…
Trending
- Quoin Pharma’s QRX003 Shows Promising Results In Netherton Syndrome Studies
- I Sailed on Royal Caribbean’s New Utopia of the Seas Cruise: My Review
- The Gabelli Global Rising Income & Dividend Fund Q3 2024 Commentary (GAGCX)
- Dow Jones Industrial Average Levels to Watch as Index Rides 9-Day Losing Streak
- Ameren Corporation (AEE) Stock Forecasts
- What a potential Nissan-Honda merger could mean for the auto industry
- Far-right Israeli minister attacks Gaza ceasefire proposal as ‘surrender deal’
- Gentex to acquire VOXX in $7.50 per share cash deal By Investing.com
- Is FirstEnergy Stock Underperforming the Nasdaq?
- Gen X: I Hate Working With Boomers and Love How Millennials View Work
- DFE: First Look Earns Sell Rating For This Europe Small-Cap Dividend ETF (NYSEARCA:DFE)
- Birkenstock Stock Rises as Shoemaker Sees Margins Improving
- Apple Inc. (AAPL) Stock Forecasts
Finance
Major car shakeup Today’s FOMC meeting will be the big news this afternoon, but overnight…
Key Takeaways Homebuilder confidence in the future increased to its highest in nearly three years…
EVGo (NASDAQ: EVGO) stock tumbled 27% through 10:05 a.m. ET Tuesday after the operator of…
 Wealth management, banking and finance concept. Smart banking with technology.D3sign | Moment | Getty ImagesThe…
Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects her favourite stories…
CALGARY, Alberta, Dec. 18, 2024 (GLOBE NEWSWIRE) — NuVista Energy Ltd (TSX:). (TSX:NVA, “NVA” or…
© 2024 swisscryptonews| All Righ RiversedÂ